Related Experiment Video

Updated: May 16, 2026

T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo
08:46

T4 Bacteriophage and E. coli Interaction in the Murine Intestine: A Prototypical Model for Studying Host-Bacteriophage Dynamics In Vivo

Published on: January 26, 2024

[Some immunological changes in children with bacterial infections treated with bacteriophages]

K I Pagava, G D Metskhvarishvili, K K Gachechiladze

    Georgian Medical News
    |December 11, 2012
    PubMed

    Insights

    Children treated with oral bacteriophages develop neutralizing antibodies, potentially limiting therapy duration. Antibody production is lower in infants, suggesting greater efficacy in this age group for bacterial infections.

    Area of Science:

    • Immunology
    • Microbiology
    • Pediatrics

    Context:

    • Bacterial infections in children are a significant health concern.
    • Bacteriophage therapy offers an alternative to antibiotics for bacterial infections.
    • Oral administration of bacteriophage cocktails is increasingly explored in pediatric care.

    Purpose:

    • To investigate immunological changes, specifically antibody production, in children receiving oral bacteriophage therapy.
    • To assess the impact of age on the immune response to bacteriophage preparations.
    • To determine if antibody formation limits the efficacy or duration of bacteriophage treatment.

    Summary:

    • This study analyzed serum samples from 65 children with various bacterial infections treated with oral bacteriophage cocktails.
    • Anti-phage neutralizing antibodies were detected in children, with prevalence increasing with age and treatment duration.
    • Antibody production was significantly lower in infants under one year, indicating a potentially more effective therapeutic window.

    Impact:

    • The development of anti-phage antibodies may limit the duration and re-usability of bacteriophage therapy in children.
    • Findings suggest bacteriophage therapy could be more effective in younger infants due to a reduced immune response.
    • This research informs clinical decisions regarding the application and monitoring of bacteriophage treatments in pediatric populations.

    More Related Videos

    Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings07:22

    Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

    Published on: August 19, 2021

    Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics09:23

    Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics

    Published on: January 5, 2024

    Related Concept Videos

    Lytic Cycle of Bacteriophages01:30

    Lytic Cycle of Bacteriophages

    Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
    Lysogenic Cycle of Bacteriophages00:43

    Lysogenic Cycle of Bacteriophages

    In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
    Viral Replication: Lysogenic Cycle01:16

    Viral Replication: Lysogenic Cycle

    The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...
    Defense Against Bacterial Pathogens01:31

    Defense Against Bacterial Pathogens

    The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
    Phagocytes
    Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
    Regulation of Bacterial Virulence01:28

    Regulation of Bacterial Virulence

    Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...